Viewing data from:

LO MINASTRIN FE

NDA

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE | N204654 | ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD

1 strength1 unique patent0 unique exclusivities

Patent Timeline

1 unique patent by expiration date

Active (1)TodayIPRPTAB Challenge

2027

2028

2029

Today

Feb. 2, 2029IPR

PTAB Proceedings

1 challenge on OB patents at the Patent Trial and Appeal Board

Trial #	Patent	Type	Petitioner	Status	Filed	Decision
IPR2015-00682	7704984	IPR	Mylan Pharmaceuticals Inc.	Institution Denied	2015-02-03	—

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

Approval Letters

3 letters from Drugs@FDA

Source: Drugs@FDA application documents.

Products (1)

#001 — 0.01MG,0.01MG,N/A;1MG,N/A,N/A

RLD

1 patent0 exclusivities▴

TABLET, CHEWABLE, TABLET;ORAL | Approved: Jul 24, 2013

Patent #	Expiration	PED	Drug Substance	Drug Product	Use Code	Delist
7704984	Feb 2, 2029	—	—	—		—